Literature DB >> 8652253

The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy.

S Kaasa1, K Bjordal, N Aaronson, T Moum, E Wist, S Hagen, A Kvikstad.   

Abstract

The EORTC Core Quality of Life questionnaire (EORTC QLQ-C30) is designed to measure cancer patients' physical, psychological and social functions. The questionnaire is composed of multi-item scales and single items. 247 patients completed the EORTC QLQ-C30 before palliative radiotherapy and 181 after palliative radiotherapy. The questionnaire was well accepted with a high completion rate in the present patient population consisting of advanced cancer patients with short life expectancy. In addition, the questionnaire was found to be useful to detect the effect of palliative radiotherapy over time. The scale reliability was excellent for all scales except the role functioning scale. Excellent criterion validity was found for the emotional functioning scale where it was correlated with GHQ-20. Performance of the questionnaire was improved after the second evaluation as compared with the first. The present study shows that the EORTC QLQ-C30 is found to be practical and valid in measuring quality of life in patients with advanced disease.

Entities:  

Mesh:

Year:  1995        PMID: 8652253     DOI: 10.1016/0959-8049(95)00296-0

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  85 in total

1.  A follow-up study of the quality of life in cancer patients with different prognoses.

Authors:  G I Ringdal; K Ringdal
Journal:  Qual Life Res       Date:  2000-02       Impact factor: 4.147

2.  Validation of the Korean version of the EORTC QLQ-C30.

Authors:  Y H Yun; Y S Park; E S Lee; S M Bang; D S Heo; S Y Park; C H You; K West
Journal:  Qual Life Res       Date:  2004-05       Impact factor: 4.147

3.  Effect of neurological dysfunction on health-related quality of life in patients with high-grade glioma.

Authors:  D Osoba; N K Aaronson; M Muller; K Sneeuw; M A Hsu; W K Yung; M Brada; E Newlands
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

4.  Criterion validity of the BBUSQ-22: a questionnaire assessing bowel and urinary tract symptoms in women.

Authors:  L Hiller; H D Bradshaw; S C Radley; S Radley
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-01-24

5.  Multidimensional constructs of the EORTC Quality of Life Questionnaire (QLQ-c30) in Korean cancer patients with heterogeneous diagnoses.

Authors:  Eun-Hyun Lee; Mison Chun; Hee-Jung Wang; Ho Yeong Lim; Jin-Hyuk Choi
Journal:  Cancer Res Treat       Date:  2005-06-30       Impact factor: 4.679

6.  Assessing the consistency of psychometric properties of the HRQoL scales within the EORTC QLQ-C30 across populations by means of the Mokken Scaling Model.

Authors:  K Ringdal; G I Ringdal; S Kaasa; K Bjordal; F Wisløff; S Sundstrøm; M J Hjermstad
Journal:  Qual Life Res       Date:  1999       Impact factor: 4.147

7.  Anxiety and depression in patients with lung cancer before and after diagnosis: findings from a population in Glasgow, Scotland.

Authors:  A Montazeri; R Milroy; D Hole; J McEwen; C R Gillis
Journal:  J Epidemiol Community Health       Date:  1998-03       Impact factor: 3.710

8.  Radiation related morbidities and their impact on quality of life in head and neck cancer patients receiving radical radiotherapy.

Authors:  M Bansal; B K Mohanti; N Shah; R Chaudhry; S Bahadur; N K Shukla
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

9.  Validity and reliability of the European Organization for Research and Treatment in Cancer Quality of Life Questionnaire (EORTC QLQ): experience from Kuwait using a sample of women with breast cancer.

Authors:  Shafika A Alawadhi; Jude U Ohaeri
Journal:  Ann Saudi Med       Date:  2010 Sep-Oct       Impact factor: 1.526

10.  Health - related quality of life of Kuwaiti women with breast cancer: a comparative study using the EORTC Quality of Life Questionnaire.

Authors:  Shafika A Alawadi; Jude U Ohaeri
Journal:  BMC Cancer       Date:  2009-07-08       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.